(Q39674865)
Statements
Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin) (English)
Cristina Oliveras-Ferraros
Alejandro Vazquez-Martin
Begoña Martin-Castilló
Maria Carmen Pérez-Martínez
Silvia Cufí
Sonia Del Barco
Luis Bernado
Eugeni López-Bonet
Javíer A Menendez
1 September 2010